SCHEMBL24435390

SCHEMBL24435390

CC(C)(C)N(C(=O)CCO)C1CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24435395 0.94 DPP4 (0.31) —
SCHEMBL24435398 0.92 ALDH1A1 (0.33) —
SCHEMBL24435391 0.91 ALDH1A1 (0.36) —
SCHEMBL24435393 0.91 ALDH1A1 (0.36) —
SCHEMBL24435397 0.91 ALDH1A1 (0.36) —
SCHEMBL18611268 0.79 DPP4 (0.31) —
SCHEMBL705608 0.72 KDM5A (0.32) —
SCHEMBL705607 0.72 KDM5A (0.32) —
SCHEMBL2757980 0.72 DPP4 (0.30) —
SCHEMBL527479 0.72 DPP4 (0.30) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230277652-A1 NUCLEIC ACID VACCINES FOR CORONAVIRUS SUZHOU ABOGEN BIOSCIENCES CO LTD (CN) 2023-09-07 — — US disclosed
US-11472766-B2 Lipid nanoparticle composition Suzhou Abogen Biosciences Co., Ltd. (CN) 2022-10-18 — — US disclosed
US-20220218816-A1 NUCLEIC ACID VACCINES FOR CORONAVIRUS Suzhou Abogen Biosciences Co., Ltd. (CN) 2022-07-14 — — US disclosed
US-20220153686-A1 LIPID NANOPARTICLE COMPOSITION Suzhou Abogen Biosciences Co., Ltd. (CN) 2022-05-19 — — US disclosed
Send feedback